Inactive Instrument

Bio Gate AG Stock Deutsche Boerse AG

Equities

DE000BGAG981

Medical Equipment, Supplies & Distribution

End-of-day quote Deutsche Boerse AG
- EUR - Intraday chart for Bio Gate AG

Financials

Sales 2024 * 8.21M 8.83M 12.09M Sales 2025 * 10M 10.77M 14.73M Capitalization 9.15M 9.84M 13.47M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 1.11 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 0.91 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 48.3%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer - 12-01-07
Corporate Officer/Principal - -
Members of the board TitleAgeSince
Director/Board Member 54 11-12-31
Chairman - -
Director/Board Member - -
More insiders
Bio-Gate AG is a Germany-based medical technology company. The Company employs silver technology to endow materials and products with antimicrobial properties, and specializes in plasmacoating, spray, additives and textile solutions, among others. It produces medical technology products, as well as technologies to refine cosmetics, consumer goods and industrial products. Its products are applied in the area of implants, skin care, cosmetics, orthopedics, industrial applications, consumer goods, would care, textiles and dental products. The Company incorporates silver particles into cosmetics, paints, veneers or plastics, or involves coating of final products, such as implants or wound dressings, with a silver-containing functional layer.
More about the company